Extracellular matrix gene expression (None)

“Extracellular matrix gene expression” refers broadly to the cellular processes governing transcriptional activation/repression and translation of genes encoding structural proteins such as collagens, fibronectin, laminins, proteoglycans—as well as regulatory molecules like growth factors—comprising the extracellular matrix. These processes determine how much and what type(s) of ECM components are produced by cells at any given time. The balance between synthesis and degradation shapes tissue architecture during development, homeostasis, wound healing/regeneration—and its dysregulation underlies pathological conditions including cancer metastasis/fibrosis/cartilage degeneration. While critical for understanding disease mechanisms and potential interventions at the systems biology level, “extracellular matrix gene expression” itself does not denote an individual molecular drug target but rather encompasses many targets within interconnected regulatory networks.

Other names

ECM gene regulationRegulation of extracellular matrix genesExpression of extracellular matrix components

Not applicable for this entry specifically; however, drugs may affect ECM composition by: inhibiting enzymes like MMPs that degrade ECM proteins, or modulating growth factor signaling pathways that regulate transcription factors controlling these genes.